1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking, Carbone et al, 2022

Discussion in 'Long Covid research' started by cassava7, Nov 9, 2022.

  1. cassava7

    cassava7 Senior Member (Voting Rights)

    Messages:
    985
    Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments.

    Individuals who recovered from COVID-19 made significantly more errors in all eye tracking tasks compared to age/sex-matched healthy controls. Furthermore, patients who were treated as inpatients performed worse compared to outpatients and controls.

    Our results show impaired inhibitory cortical control in individuals who recovered from COVID-19. The association between disease severity and its sequelae may contribute to a better understanding of post-COVID-19 cognitive function.

    Open access: https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.51675
     
  2. cassava7

    cassava7 Senior Member (Voting Rights)

    Messages:
    985
    Of note:

    “We found no correlation with MoCA subscores and saccadic performance, possibly due to a ceiling effect. The MoCA is a rapid cognitive screening tool, and our patients had normal scores.”

    The MoCA is the Montreal Cognitive Assessment test.

    A limitation of the study is that inpatients, and older patients, had more pronounced eye tracking impairments than outpatients. I am not sure how well it would translate to ME-like long Covid.
     
    Last edited: Nov 9, 2022

Share This Page